1. The part of the plaintiff's conjunctive claim for subrogation against the defendant East Medicine Co., Ltd.

1. Basic facts

A. The Plaintiff, as an insurer of the health insurance, is a corporation established to impose insurance premiums and pay insurance benefit costs in accordance with the National Health Insurance Act. 2) The Plaintiff is a company that manufactures and sells drugs, and is engaged in the Defendant East Drugs Co., Ltd. (hereinafter referred to as “Dongdong medicine”), Japan Pharmaceutical Co., Ltd. (hereinafter referred to as “Seoul Pharmaceutical Co., Ltd.”), Taebol Medicine Co., Ltd. (hereinafter referred to as “Tol Medicine”), Cream Co., Ltd. (hereinafter referred to as “Cina”), and the subsidiary Party (hereinafter referred to as “Cina”), etc.

3) Defendant A Co., Ltd (hereinafter “Defendant A”)

(2) According to Article 26 of the Pharmaceutical Affairs Act (wholly amended by Act No. 8365 of Apr. 11, 2007) and Article 23 of the Enforcement Rule of the Pharmaceutical Affairs Act (amended by Ordinance of the Ministry of Health and Welfare No. 332 of Oct. 7, 2005), any person who intends to engage in the manufacture of drugs is a same-sex testing institution, and any person who intends to modify permitted matters by item from the Commissioner of the Korea Food and Drug Administration (hereinafter referred to as the "Administrator of the Korea Food and Drug Administration"), and any person who intends to obtain permission for the manufacture of drugs shall obtain permission for the modification of permitted matters, and a person who intends to obtain permission for the manufacture of drugs shall obtain permission for the modification of permitted matters by item from the Commissioner of the Korea Food and Drug Administration (hereinafter referred to as the "Administrator of the Korea Food and Drug Administration"), which is a special drug product manufactured (hereinafter referred to as "import drug") after January 1, 1989, the application for permission for the manufacture of drugs or the same-sex test (hereinafter referred to the same-sex test data).

2. The same-sex test is an internal test for the proof of the same-sex sex, whose principal ingredients are absorption into the general cycle blood.